Status:
COMPLETED
Phamacological Reversal of Airway Instability During Sedation
Lead Sponsor:
University of Rochester
Conditions:
Upper Airway Obstruction
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
The investigators are attempting to demonstrate a decrease in the frequency and severity of sedation-induced respiratory arrhythmias(central and obstructive apneas) with pharmacological pre-treatment ...
Detailed Description
One of the most serious side effects of drugs administered for sedation is untoward respiratory events. The relative prevalence of such events is thought to be high, occurring in up to 41% of patients...
Eligibility Criteria
Inclusion
- Ages 18-45
- BMI below 25
- Healthy males
Exclusion
- Psychiatric illness
- Substance abuse
- Airway disorders
- Bleeding abnormatlities
- Claustrophobia
- Sleep apnea.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01171118
Start Date
August 1 2009
End Date
August 1 2011
Last Update
April 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642